Instructions and precautions for taking Lynparza (Olaparib, Lipadro)
1. Instructions for use
1.Indications: Lynparza is mainly used for the initial treatment and maintenance treatment of advanced epithelial ovarian cancer, fallopian tube cancer or primary peritoneal cancer carrying germline or somatic BRCA mutations. It is also suitable for the treatment of platinum-sensitive recurrent cases and prostate cancer.
2.Dosage: The recommended dose is 300mg twice a day (if it is 150mg tablets, you need to take two tablets). The tablet should be swallowed whole, whether with a meal or on an empty stomach. It is important that the tablets are not broken, crushed, dissolved or chewed and that they are taken as planned.

2. Precautions
1.Food interactions: Grapefruit, grapefruit juice, lime, and lime juice should be avoided while taking Lynparza because these foods may increase the blood concentration of Lynparza. At the same time, caffeine can reduce the blood concentration of Lynparza, so caffeinated foods and drinks should also be avoided.
2.Adverse reactions: Common adverse reactions include nausea, fatigue, anemia, vomiting, diarrhea, decreased appetite, etc. If serious adverse reactions occur, seek medical attention immediately.
3.Special management: For blood system problems such as anemia, thrombocytopenia or leukopenia, it is necessary to monitor and adjust medication under the guidance of a doctor, which may include dietary adjustment or drug treatment.
4.Regular monitoring: During the period of taking Lynparza, relevant indicators should be monitored regularly to detect and deal with possible problems in a timely manner.
5.Follow the doctor’s advice: Patients must strictly follow the doctor’s instructions to take medications and are not allowed to increase or decrease the dosage or change the medication method on their own.
Lynparza is an effective anti-cancer drug, but special attention should be paid to food and drug interactions and possible adverse reactions during use. Patients should regularly monitor their physical condition and maintain close communication with their doctors to ensure the safety and effectiveness of their medication.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)